These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20192794)

  • 21. Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?
    Stahl SM
    CNS Spectr; 2008 Feb; 13(2):115-8. PubMed ID: 18227742
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenetics and the treatment of asthma.
    Isidoro-García M; Sánchez-Martín A; García-Sánchez A; Sanz C; García-Berrocal B; Dávila I
    Pharmacogenomics; 2017 Aug; 18(13):1271-1280. PubMed ID: 28776467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.
    Soyka M; Mutschler J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():148-61. PubMed ID: 26577297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics: the promise of personalized medicine.
    Mancinelli L; Cronin M; Sadée W
    AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses.
    Le Foll B
    Prog Brain Res; 2016; 224():419-47. PubMed ID: 26822369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of pharmacogenetic techniques in drug abuse research.
    Marley RJ; Elmer GI; Goldberg SR
    Pharmacol Ther; 1992; 53(2):217-37. PubMed ID: 1641407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.
    Uhl GR; Drgon T; Johnson C; Li CY; Contoreggi C; Hess J; Naiman D; Liu QR
    Ann N Y Acad Sci; 2008 Oct; 1141():318-81. PubMed ID: 18991966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics: the promise of personalized medicine for CNS disorders.
    de Leon J
    Neuropsychopharmacology; 2009 Jan; 34(1):159-72. PubMed ID: 18800072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Race, distributive justice and the promise of pharmacogenomics: ethical considerations.
    Lee SS
    Am J Pharmacogenomics; 2003; 3(6):385-92. PubMed ID: 14672519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human genetic variation and personalized medicine.
    Agrawal S; Khan F
    Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BeadArray-based solutions for enabling the promise of pharmacogenomics.
    Fan JB; Hu S; Craumer W; Barker D
    Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Pharmacogenomics in Personalized Medicine.
    Singh DB
    Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized medicine means planning for your future health. Analyzing a patient's health risks and focusing on prevention and health planning are key components of the 21st century's new health care.
    Duke Med Health News; 2008 Nov; 14(11):6-7. PubMed ID: 19031593
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenomics and personalized use of drugs.
    Wang JF; Wei DQ; Chou KC
    Curr Top Med Chem; 2008; 8(18):1573-9. PubMed ID: 19075768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
    Harrison N
    Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.